German Pharmaceuticals & Biotech Healthy potentially undervalued

Dermapharm Holding

Market Cap: €2.0b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

Bayer

Market Cap: €47.2b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.

Merck KGaA

Market Cap: €60.0b

Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.

Formycon

Market Cap: €341.1m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.